AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to evaluate the safety and efficacy of AGN-151586 over a range of doses for the treatment of moderate to severe glabellar lines (GL).
Epistemonikos ID: c0429ef6cef639b99ed8d5e59a0932a37d2262a2
First added on: May 22, 2024